Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases
source: pixabay.com

Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases

  For many families, when their child is born with developmental delays, there may be weeks, months, or even years that go by without a diagnosis. During this time, parents…

Continue Reading Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases
Experimental Treatment for Charcot-Marie-Tooth Disease Gets FDA Fast Track Designation
annca / Pixabay

Experimental Treatment for Charcot-Marie-Tooth Disease Gets FDA Fast Track Designation

According to a story from Digital Journal, the biopharmaceutical company Acceleron Pharma, Inc., recently announced that its investigational drug candidate ACE-083 was granted Fast Track designation from the US Food…

Continue Reading Experimental Treatment for Charcot-Marie-Tooth Disease Gets FDA Fast Track Designation
Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
mwooten / Pixabay

Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment

According to a story from BioPortfolio, Celgene Corporation and bluebird bio, Inc., have recently announced that enrollment for a pivotal Phase 2 study testing an experimental therapy for relapsed/refractory multiple…

Continue Reading Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins
qimono / Pixabay

Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins

According to a story from globenewswire.com, the biopharmaceutical company PhaseBio Pharmaceuticals has recently announced that the first patient has been dosed in a Phase 2b clinical trial of the company's…

Continue Reading Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins
Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Free-Photos / Pixabay

Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

According to a story from pm360online.com, the drug developer Novartis has recently announced that the company's gene therapy Luxturna has gained approval in the EU as a treatment for Leber's…

Continue Reading Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

An Experimental Biopsy Approach Could Improve Diffuse Intrinsic Pontine Glioma Monitoring

According to a story from tgen.org, a team of scientists from the Translational Genomics Research Institute (TGEN) have recently initiated a study that will test the effectiveness of liquid biopsy…

Continue Reading An Experimental Biopsy Approach Could Improve Diffuse Intrinsic Pontine Glioma Monitoring
Research Highlights Relationship Between Nonalcoholic Steatohepatitis and Heart Health
Free-Photos / Pixabay

Research Highlights Relationship Between Nonalcoholic Steatohepatitis and Heart Health

According to a story from Health Canal, a team of researchers led by Dr. Mohammad Siddiqui of Virginia Commonwealth University (VCU) recently released a study which further highlights the relationship…

Continue Reading Research Highlights Relationship Between Nonalcoholic Steatohepatitis and Heart Health
Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy
AxxLC / Pixabay

Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy

According to a story from the Farmington Daily Times, Dr. C. Frank Bennett, who grew up in Aztec, NM, and his collaborator Dr. Adrian Krainer, were both jointly awarded the…

Continue Reading Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy